Website & contact details
- Website
Aristo Pharma Limited
- Incorporated
- 18 September 2014 (12 years)
- Previously known as
- Ceb Pharma Limited (until 1 March 2017)This list may be incomplete. See all names on Companies House
- Industry
- Other professional, scientific and technical activities n.e.c. (74909)
- Directors
- Marian KomarJohn Hudson KriwetIan Alan Chatterton
- Owned by
- Aristo Pharma GMBH
- Accounts type
- Small
- Region
- East of England
- Address
- The North Suite Avro HouseLancaster Way Business ParkElyCB6 3NW
Filing status
- Accounts due
- 30 September 2027
- Last accounts
- 31 December 2025
- Conf. stmt due
- 14 July 2027
- Last conf. stmt
- 30 June 2026
Officers 3 active
Officer details are public data from the Companies House register.
Komar, Marian
Director · Appointed 1 January 2025
Slovak
Born August 1981 (45)
Kriwet, John Hudson
Director · Appointed 1 January 2025
German
Born May 1969 (57)
Chatterton, Ian Alan
Director · Appointed 1 April 2021
British
Born June 1974 (52)
Officer history (5 former)
1 January 2025
Appointed Kriwet, John Hudson as Director
1 January 2025
Appointed Komar, Marian as Director
31 December 2024
Resigned Williamson, Kenneth Lawrie, Dr as Director
3 January 2024
Resigned Fletcher, John Haydn Francis as Director
1 April 2021
Appointed Chatterton, Ian Alan as Director
5 September 2016
Resigned Chatterton, Ian Alan as Director
1 July 2016
Resigned Coates, John, Dr as Director
23 June 2016
18 September 2014
18 September 2014
Appointed Fletcher, John Haydn Francis as Director
18 September 2014
Appointed Chatterton, Ian Alan as Director
18 September 2014
Appointed Williamson, Kenneth Lawrie, Dr as Director
18 September 2014
Appointed Coates, John, Dr as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Aristo Pharma GMBH
Corporate entity · Notified 20 June 2016
Owns 75–100% of shares
Limited
Financials
Balance sheet as at 31 December 2025 · small accounts
- Cash
- £212,286
- Current Ratio
- 1.8x
Trend
Shareholder Funds
Balance sheet detail
| 2025 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Fixed Assets | £0 | £1,253 | £1,779 | £1,513 | £2,178 | £1,495 |
| Current Assets | £762,038 | £560,811 | £542,996 | £355,539 | £344,761 | £211,436 |
| Debtors | £549,752 | £198,842 | £208,956 | £179,330 | £245,687 | £172,955 |
| Cash | £212,286 | £361,969 | £334,040 | £176,209 | £99,074 | £38,481 |
| Creditors (< 1 year) | £423,907 | £346,485 | £314,897 | £178,634 | £141,174 | £50,662 |
| Creditors (> 1 year) | £0 | £75,755 | £76,206 | £153,918 | £148,678 | |
| Net Current Assets | £338,131 | £214,326 | £228,099 | £176,905 | £203,587 | £160,774 |
| Net Assets | £215,579 | £154,123 | £102,212 | £51,847 | £13,591 | |
| Shareholder Funds | £338,131 | £215,579 | £154,123 | £102,212 | £51,847 | £13,591 |
What Aristo Pharma say about themselves
“Our philosophy is simple: we produce medicines, which are both high quality and cost-effective for patients. Because every person has a right to health.”
Filings
Filing history not loaded yet. See it on Companies House
Other companies in this industry
Beckenham
Birmingham
Reading
London
London
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →